NDC 0069-0400-01 - Zithromax
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0069-0400
- Requested NDC
- 0069-0400-01
- Package NDCs from labels
- 0069-0400-01, 0069-0400-10
- Manufacturer
- Pfizer Laboratories Div Pfizer Inc | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company
- Effective date
- 2026-09-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Zithromax | Pfizer Laboratories Div Pfizer Inc | Pharmacia & Upjohn Company LLC | Pfizer Ireland Pharmaceuticals Unlimited Company | 2026-09-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0069-0400-01 | Zithromax | 5 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 5 | 25 | |
| 0069-0400-10 | Zithromax | 10 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 10 | 25 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0069-0400 | ZITHROMAX (AZITHROMYCIN DIHYDRATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | 25 | Current NDC, Legacy NDC, 2 package rows | 20250212_8d24bacb-feff-4c6a-b8df-625e1435387a.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0069-0400-01 | EA - Each | 0069-0400 | d7c08308-f15a-4aba-9d7c-7c2716a206c1 | 1 | 2014-04-03 |
| 0069-0400-10 | EA - Each | 0069-0400 | e0653e4e-6e09-4e11-a661-10801d9d44eb | 1 | 2014-04-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| AZITHROMYCIN DIHYDRATE | ACTIVE INGREDIENT | 5FD1131I7S | ZITHROMAX (AZITHROMYCIN DIHYDRATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | 7 | |
| AZITHROMYCIN ANHYDROUS | ACTIVE MOIETY | J2KLZ20U1M | ZITHROMAX (AZITHROMYCIN DIHYDRATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | 7 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | ZITHROMAX (AZITHROMYCIN DIHYDRATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | 7 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | ZITHROMAX (AZITHROMYCIN DIHYDRATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | 7 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Azithromycin | AZITHROMYCIN | NuCare Pharmaceuticals,Inc. | a9cdb5ae-2aeb-c598-e053-2a95a90a8062 | 2026-07-30 | Warnings, Adverse reactions | 5FD1131I7S |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | NuCare Pharmaceuticals,Inc. | 21c67de0-3a4e-caab-e063-6394a90ae3cd | 2026-07-30 | Warnings, Adverse reactions | 5FD1131I7S |
| Azithromycin | AZITHROMYCIN | Sandoz Inc | ec619299-e0ef-44dd-acdb-8c53bbfc5b8a | 2026-07-30 | Warnings, Adverse reactions | 5FD1131I7S |
| Azithromycin | AZITHROMYCIN | A-S Medication Solutions | 882f71b1-b153-4856-b4a7-1a29ae9cf247 | 2026-07-29 | Warnings, Adverse reactions | 5FD1131I7S |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | PD-Rx Pharmaceuticals, Inc. | 0c926669-62b2-4ad3-8289-173c5818a9c1 | 2026-07-29 | Warnings, Adverse reactions | 5FD1131I7S |
| Azithromycin | AZITHROMYCIN | Eugia US LLC | 7b81436e-d14a-4353-a22d-253f45e2e576 | 2026-07-27 | Warnings, Adverse reactions | 1668238 |
| Zithromax | AZITHROMYCIN DIHYDRATE | Pfizer Laboratories Div Pfizer Inc | db52b91e-79f7-4cc1-9564-f2eee8e31c45 | 2026-07-24 | Warnings, Adverse reactions | 5FD1131I7S |
| Zithromax | AZITHROMYCIN DIHYDRATE | Pfizer Laboratories Div Pfizer Inc | 3b631aa1-2d46-40bc-a614-d698301ea4f9 | 2026-07-24 | Warnings, Adverse reactions | NDA050733 1668240 1668238 5FD1131I7S |
| Azithromycin | AZITHROMYCIN | A-S Medication Solutions | 3b7e16b1-9a3c-4e3a-8411-841a708afe45 | 2026-07-23 | Warnings, Adverse reactions | 5FD1131I7S |
| Azithromycin | AZITHROMYCIN | A-S Medication Solutions | 58308e8b-57bd-4e82-a2e8-24aac63194cd | 2026-07-23 | Warnings, Adverse reactions | 5FD1131I7S |
| Xenleta | LEFAMULIN ACETATE | Meitheal Pharmaceuticals Inc. | eb972ea8-7502-422e-84bb-66cb8e93ca06 | 2026-07-22 | Warnings, Adverse reactions | XF417D3PSL |
| Azithromycin | AZITHROMYCIN | Bryant Ranch Prepack | 2a8010dc-700f-45d3-94ca-ebe4a51acc1b | 2026-07-20 | Warnings, Adverse reactions | 5FD1131I7S |
| Azithromycin | AZITHROMYCIN | Bryant Ranch Prepack | 6caeda98-7020-413a-9461-04f476dad4ba | 2026-07-20 | Warnings, Adverse reactions | 5FD1131I7S |
| Azithromycin | AZITHROMYCIN | A-S Medication Solutions | 3c4861f2-825e-4e3b-9907-9658a849079e | 2026-07-16 | Warnings, Adverse reactions | 5FD1131I7S |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | Bryant Ranch Prepack | 7d78cd8e-0c63-46d6-b018-939fcbbe42a6 | 2026-06-24 | Warnings, Adverse reactions | 5FD1131I7S |
| Azithromycin | AZITHROMYCIN | Preferred Pharmaceuticals Inc. | 661ff7a6-6394-493d-a307-a1f607e5d117 | 2026-06-16 | Warnings, Adverse reactions | 5FD1131I7S |
| E-Z-GAS II | ANTACID/ANTIFLATULENT | E-Z-EM, INC. | 4e12e1cb-b033-076d-e054-00144ff8d46c | 2026-06-15 | Warnings | XF417D3PSL |
| Azithromycin Dihydrate | AZITHROMYCIN DIHYDRATE | REMEDYREPACK INC. | 7711e846-0bb3-486c-8511-f445e264cd98 | 2026-06-12 | Warnings, Adverse reactions | 5FD1131I7S |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Cardinal Health 107, LLC | b3d5225c-0ee4-481e-b9ec-bc5e1321096d | 2026-06-12 | Adverse reactions | XF417D3PSL |
| Alka-Seltzer Original | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | Select Consumer Group | 3ca80d74-1e8b-49d9-e063-6394a90a4312 | 2026-05-24 | Warnings | XF417D3PSL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.